Epidemiology of MRSA and current strategies in Europe and Japan

Axel Kramer, Hans Wagenvoort, Christina Åhrén, Inka Daniels-Haardt, Philippe Hartemann, Hiro Kobayashi, Andrea Kurcz, Juan Picazo, Gaetano Privitera & Ojan Assadian
The prevalence of health-care associated infections caused by multi-drug resistant organisms has significantly increased over the past decade. Among these organisms, Methicillin-resistant Staphylococcus aureus (MRSA) plays a prominent and increasing role. Because of consequences for patients and the economic burden in course of prolonged treatment following MRSA infections and additional indirect costs for e.g. isolation or antiseptic treatment, this trend will further damage European health-care systems. In 2006, a workshop was initiated at the 8th...